Covaxin gets WHO approval: A look at its journey to recognition

Seven months after Hyderabad-based Bharat Biotech submitted EOI (Expression of Interest) to the World Health Organization (WHO) for its Covid-19 vaccine's Emergency Use Listing (EUL), the global health body on November 3 gave a green signal to the indigenously-developed Covaxin.

Related Keywords

India ,Brazil ,Pune ,Maharashtra ,Bharat ,Soumya Swaminathan ,Krishna Ella ,Vardhan Shringla ,Balram Bhargava ,National Institute Of Virology ,World Health Organization ,Hyderabad Based Bharat Biotech ,Emergency Use Listing ,Bharat Biotech ,National Institute ,Scientist Soumya Swaminathan ,Foreign Secretary Harsh Vardhan Shringla ,General Dr Balram Bhargava ,United Kingdom Variant ,Coronavirus ,Coronavirus Vaccine ,Covaxin ,Covid 19 ,Covid 19 Vaccine ,Ndia News ,